You are entitled to your opinion and I opine that TRXC is not a Robotic Surgical Platform. I surmise this because the genesis of Surgibot is the Spider System, which was not and is not Robotic (advanced lap). Further it was not well received by the medical community in the three years after FDA clearance and your President has admitted that "surgeons recommended changes".
Most importantly you continually reference that you will be coming to market sooner, but have provided no corporate timeline for commercialization like Titan has. Regardless, your program has spent upwards of $150 million of investor resources thus far and decimated long term shareholders with your recent R/S and $50 Million equity raise. Cut some of the over 100 staff and you wouldn't be burning so much cash. What do these people do everyday?
Bottom line isn't which technology can get to market first, it's which will be well received by the medical community and adopted...
News 
Market Data 
Discover 
